Why this market is moving now
- Novo Nordisk's NovoCare Pharmacy self-pay channel opened in March 2025 and reached around 70,000 weekly Wegovy injection prescriptions by January 2026.
- The Wegovy pill launched on 5 January 2026 with self-pay prices from USD 149 a month.
Key figures
Each figure names the source it came from. Open the source list below to read the quoted line.
| Figure | Value | Year | Source |
|---|---|---|---|
| Novo Nordisk launched NovoCare Pharmacy, its direct-to-patient self-pay channel for Wegovy, in March 2025. | March 2025 launch date | 2025 | Novo Nordisk |
| Injectable Wegovy self-pay prescriptions via retail NovoCare Pharmacy, including telehealth collaborations, were around 70,000 per week as of 23 January 2026. | 70,000 prescriptions per week | 2026 | Novo Nordisk |
| The Wegovy pill was approved by the FDA on 22 December 2025 and launched on 5 January 2026, available through more than 70,000 pharmacies, NovoCare Pharmacy and eight telehealth organisations. | 70,000+ pharmacies | 2026 | Novo Nordisk |
| Wegovy pill total weekly prescriptions were around 50,000 as of 23 January 2026, mainly in the self-pay channel. | 50,000 prescriptions per week | 2026 | Novo Nordisk |
| Self-pay prices for the Wegovy pill ranged from USD 149 to USD 299 per month depending on dose, as of early 2026. | 149 to 299 USD per month | 2026 | Novo Nordisk |
| Novo Nordisk estimates around 50 million people with obesity in the US have Wegovy coverage, including more than 5 million via Medicaid. | 50 million people with Wegovy coverage (estimate) | 2026 | Novo Nordisk |
| TrumpRx.gov lists Wegovy Pill at $149 a month, Wegovy Pen at $199 a month and Zepbound at $299 a month, as shown on the site on 27 October 2026. | 149 USD per month (Wegovy Pill, as listed) | 2026 | TrumpRx.gov |
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Novo Nordisk: Financial report for the period 1 January 2025 to 31 December 2025 (2026-02-03)
Quoted lines
- Figure 1
NovoCare® Pharmacy was launched in March 2025.
- Figure 2
amount to around 70,000 weekly prescriptions as of 23 January 2026.
- Figure 3
Wegovy® pill is made available across more than 70,000 pharmacies including the NovoCare® Pharmacy platform and across eight telehealth organisations.
- Figure 4
total weekly prescriptions amount to around 50,000, mainly driven by the 1.5 mg starter dose in the self-pay channel.
- Figure 5
Self-pay price points currently range from USD 149 per month to USD 299 per month, depending on dose.
- Figure 6
It is estimated that around 50 million people with obesity have Wegovy® coverage in the US
- Figure 1
- TrumpRx.gov: TrumpRx (2026-10-27)
Quoted lines
- Figure 7
Wegovy Pill $149/mo
- Figure 7
Companies to watch
Novo Nordisk (NovoCare Pharmacy)
Launched NovoCare Pharmacy in March 2025; around 70,000 weekly self-pay Wegovy injection prescriptions in January 2026.
Eli Lilly (LillyDirect)
Names LillyDirect as one of its patient-access platforms in its Q4 2025 earnings release (https://www.sec.gov/Archives/edgar/data/59478/000005947826000008/q425lillysalesandearningsp.htm).
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the United States market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
What is NovoCare Pharmacy?
NovoCare Pharmacy is Novo Nordisk's direct-to-patient channel, launched in March 2025 according to its 2025 financial report. It ships Wegovy to self-pay patients.
How many people use self-pay GLP-1 channels?
Novo Nordisk reported around 70,000 weekly self-pay Wegovy injection prescriptions via NovoCare Pharmacy and telehealth partners as of 23 January 2026.
How much does the Wegovy pill cost without insurance?
Novo Nordisk said self-pay prices ranged from USD 149 to USD 299 per month, depending on dose, as of its February 2026 report.
What does TrumpRx list?
On 27 October 2026 TrumpRx.gov listed Wegovy Pill at $149 a month, Wegovy Pen at $199 and Zepbound at $299. Prices can change.
How many Americans have Wegovy coverage?
Novo Nordisk estimates around 50 million people with obesity have Wegovy coverage in the US, including more than 5 million via Medicaid.
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline